Purdue Pharma agreed to pay $270 million to the Oklahoma state attorney general on March 26, 2019 for its painkiller medication, OxyContin, for aggressively marketing its drug that led to an epidemic of deaths in the state. The settlement includes money that will establish addiction treatment and research centers and money that will go directly...Read More
Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co. Ltd. have reached a confidential settlement regarding the drug Abilify with plaintiffs in the multi district litigation (MDL) on February 26, 2019. The drug is meant for antipsychotic purposes to treat schizophrenia and bipolar disorders. However, Abilify has also been known to cause side effects of compulsive behaviors,...Read More
Recently, this question was addressed by the Maryland Court of Special Appeals in Netro v. Greater Balt. Med. Ctr., Inc., No. 1990, 2018 Md. App. LEXIS 679 (App. July 5, 2018). In Netro, the Fourth Circuit added to the budding list of jurisdictions addressing who is able to sue under the private cause of action...Read More
An updated Worker’s Compensation Medicare Set-Aside (“WCMSA”) reference guide has been issued. The revised guide includes: Fields formerly labeled as “HICN” have been labeled as “Medicare ID” and can accept either Health Insurance Claim Number (“HICN”) or the new Medicare Beneficiary Identifier; The link to the CDC Life Expectancy Table has been updated; and The...Read More
MSP Recovery, LLC, a leading Medicare and Medicaid Secondary Payer Act recovery specialist, today announced that it has successfully completed a System Organization Controls (SOC) 2® Type I Audit examination for their Secondary Payer Recovery Services System. MSP retained international business advisory firm Skoda Minotti for its SOC 2® audit work. MSP selected Skoda Minotti...Read More
Two recent legal decisions out of the Eleventh Judicial Circuit in and for Miami Dade County indicate that Medicare Advantage Organizations (MAOs) may be able to obtain reimbursement from no-fault liability carriers pursuant to Medicare Secondary Payer law on a class-wide basis. On April 20, 2017, the Honorable Judge Antonio Arzola entered a 56-page order...Read More
After several wins at the U.S. Court of Appeals for the 11th Circuit, MSP Recovery made history again obtaining class certification for Medicare Advantage Organizations based on the principles of Medicare Secondary Payer law, against IDS Insurance Company. On April 20, 2017, the Honorable Judge Antonio Arzola entered a 56-page Order Granting the Motion to...Read More
Lawyers: 11th Circuit Medicare Ruling Could Be Worth Billions by Katheryn Hayes Tucker A federal appeals court decision analyzing the Medicare Secondary Payer Act could put the nation’s largest automobile insurance companies and other providers on the hook to pay billions of dollars in Medicare reimbursement. “This is a humongous victory,” said John Ruiz of...Read More
Insurance company IDS’ attempt to stop MSP’s class action from moving forward is denied by the appellate court requiring a face off between IDS and MSP in less than 30 days where insurer is exposed to millions in repayment.On Monday, August 1st, 2016, MSP Recovery Law Firm secured an appellate victory as the Third District...Read More
On August 8, 2016, the United States Court of Appeals, in Humana Medical Plan v. Western Heritage, held that the Medicare Secondary Payer Act (“MSP Act”) “clearly indicates” that a Medicare Advantage Organization (“MAO”) may bring a private cause of action” against a primary plan, which completely supports MSP Recovery Law Firm’s (“MSP Recovery”) long-held...Read More
